TABLE 5.

Patients Who Received Further ¹⁷⁷Lu-PSMA on Progression

	No. of 177Lu-PSMA cycles		Best % PSA decline		PSA progression-free survival* (d)
Patient no.	Initial	Retreatment	Initial	Retreatment	Initial	Retreatment
2	4	2	39	60	485	106
3	4	2	94	64	249	75
5	2	3	99	80	248	259
7	4	3	92	54	538	132
18	3	3	100	98	566	432
22	4	2	89	70	314	90
23	4	5	97	63	469	291
24	4	1	15	No response	266	No response
29	4	1	100	85	929	In follow-up
32	4	1	50	No response	245	No response
34	4	2	100	No response	273	No response
35	4	4	99	98	296	237
38	2	3	100	98	293	179
44	4	1	91	73	302	123
45	4	1	69	No response	484	No response

^*“Initial” measured from date of first treatment to PSA nadir, and “Retreatment” measured from date of treatment to PSA nadir.